Akums Drugs and Pharmaceutical (AKUMS) — Net Asset Quality Index
Akums Drugs and Pharmaceutical (AKUMS) has a Net Asset Quality Index of 61.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs51.59 Billion minus total liabilities of Rs19.91 Billion yields net assets of Rs31.68 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Akums Drugs and Pharmaceutical (AKUMS) liquidity interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Akums Drugs and Pharmaceutical Net Asset Quality Index Over Time (2022–2025)
This chart shows how Akums Drugs and Pharmaceutical's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the index stands at 61.4%, representing net assets of Rs31.68 Billion against total assets of Rs51.59 Billion INR. Explore Akums Drugs and Pharmaceutical operating cash flow efficiency to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Akums Drugs and Pharmaceutical (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Akums Drugs and Pharmaceutical from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see AKUMS company net worth.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.5% | Rs30.64 Billion | Rs41.13 Billion | Rs10.50 Billion | ▲ +54.0 pp |
| 2024 | 20.5% | Rs7.20 Billion | Rs35.16 Billion | Rs27.96 Billion | ▼ -1.7 pp |
| 2023 | 22.1% | Rs7.23 Billion | Rs32.67 Billion | Rs25.43 Billion | ▲ +1.8 pp |
| 2022 | 20.4% | Rs6.25 Billion | Rs30.69 Billion | Rs24.44 Billion | — |